Loading...
Login/Register
Welcome
Profile
Log Off
text
title
chapter title
keyword
WHO Home
WHO Health Systems and Services
WHO Medicines
WHO sites
Medicines Documentation home
Search
Titles A-Z
Subjects
Keywords
Series and Periodicals
Publishers
Authors A-Z
Regions
Countries
Index
Sub-collections
Public
sub-collections
Expand Document
|
Expand Chapter
|
Full TOC
|
Printable HTML version
::
Themes & Keywords
·
Keywords
>
pharmaceuticals newsletter
WHO Pharmaceuticals Newsletter 1997, No. 11&12
(1997; 24 pages)
Table of Contents
Regulatory actions
Acetylsalicylic acid and paracetamol - prescription control: United Kingdom
Chlormezanone - marketing authorization withdrawn: Germany
Counterfeit antimalarial detected: Kenya
Diphenhydramine - warning statements: United States of America
Geriatric use - added to labelling: United States of America
Herbal “Fen-Phen” - warning concerning “natural” anti-obesity alternatives: United States of America
HIV protease inhibitors - hyperglycaemia: United Kingdom
Irinotecan - revised data sheet: warning & precautions for use: Japan
Lamotrigine - warning: severe cutaneous reactions: Australia
Laxatives containing phenolphthalein - recommendation to revoke marketing authorization: Germany
Levothyroxine sodium - new drug applications to be submitted: United States of America
Lysine amidotrizoate in ionic contrast media - withdrawn: Germany
Melatonin - prescription control: New Zealand
Metamizole sodium - prohibited: Nepal
NSAIDs, including acetylsalicylic acid - proposed risk-based framework: New Zealand
Paediatric data - labelling to be required for new drugs: United States of America
Paracetamol - restrictive measures: Ireland
Pemoline - withdrawn: hepatotoxicity: United Kingdom
Sodium hydrogen bicarbonate (paediatric) - prohibited: Nepal
Suxamethonium chloride - warnings: cardiac arrest and hyperkalaemia: United States of America
Terfenadine - restrictive measures: Ireland
Terfenadine and terfenadine/pseudoephedrine - warnings concerning interactions: United States of America
Tramadol - not recommended as first choice for moderate pain: Norway
Tramadol - rescheduled: Oman
Trihexyphenidyl - rescheduled: Oman
Vigabatrin - visual field defects: Australia
Women in clinical trials - proposed rule: United States of America
Zafirlukast - possible association with Churg-Strauss syndrome: United States of America
Drug surveillance
Alendronic acid - oesophagitis: Australia
Benzodiazepines in pregnancy and lactation - reminder: to be avoided: United Kingdom
Drug-induced gynaecomastia - review of reports: Australia
Ginkgo biloba - spontaneous haemorrhage: New Zealand
Hydroxyamfetamine/tropicamide (Paremyd
R
) - adverse reactions: United States of America
Methotrexate (low-dose) - blood dyscrasias and other adverse reactions: United Kingdom
Pethidine - convulsions: Australia
Pyrithyldione/diphenhydramine - agranulocytosis: Spain
Therapeutic switches - evaluation of risks: call for data: United States of America
New developments
Anagrelide - approved in essential thrombocythaemia: United States of America
Thalidomide - interim approval for use in leprosy: United States of America
Recent approvals
Medical devices
CFC-containing metered dose inhalers (MDIs) - still available for patients with asthma or COPD: United States of America
CFCs - decision concerning use: revision: Switzerland
Excimer laser systems - legal action taken against unapproved devices: United States of America
Group B streptococcal antigen test kits - potentially fatal misdiagnoses: United States of America
Home-use test kits - warning: United States of America
Incontinence product - implanted device approved: United States of America
Knee cartilage repair - accelerated approval of autologous cell therapy: United States of America
Latex-containing devices - labelling required: United States of America
Medical devices - software validation: guidance available: United States of America
Temporomandibular joint prostheses - premarket approval to be required: United States of America
General information
Broadcast advertisements - draft guidance document available: United States of America
Computerized systems used in clinical trials - draft guidance document available: United States of America
Donors of human tissue for transplantation - guidance for screening and testing available: United States of America
Medication errors - guidelines for injectable benzodiazepines: United States of America
Veterinary medicine
Chlortetracycline and tetracycline in veterinary medicines - revised package inserts: Germany
Eprinomectin - approved for parasite control in cattle: United States of America
Pharmacovigilance of veterinary medicines - draft guidelines: EC
WHO Pharmaceuticals Newsletter 1997, No. 11&12
WHO.INT
World Health Organization
Essential Drugs and Medicines Policy
Contacts
|
E-mail scams
|
Employment
|
FAQs
|
Feedback
|
Privacy
|
RSS feeds
© WHO 2012
Last updated: April 24, 2012